Abstract:The 17q21.31 MAPT locus contains an inversion polymorphism defined by two common haplotype clades (H1 and H2). The H1 clade increases risk for several sporadic neurodegenerative disorders characterized by brain region-specific neuronal loss, including APOE-ε4-negative Alzheimer's disease (AD). However, the mechanisms driving H1-associated pathogenesis and this considerable phenotypic pleiotropy remain unclear. Compromised genome integrity apparently plays a role in neurodegenerative disease. However, somatic mosaicism in the AD brain is largely unexplored. Hence we hypothesized that H1 promotes brain somatic mosaicism in a region-specific manner. We constructed a GATK MuTect2 pipeline that calls somatic single nucleotide variants (sSNVs) in unpaired whole genome sequencing (WGS) data, applies quality control filters, calculates subject-level autosome-wide somatic variant burden (sSNV count normalized by the sum of WGS coverage), and compares this burden across 17q21.31 diplotypes and in AD vs controls using linear regression adjusted for sex, age, APOE genotype, ancestry, AD status, H1 dosage, and brain region as appropriate. We undertook preliminary analyses of blood WGS data generated from APOE-ε4-positive National Institute on Aging-Late Onset Alzheimer's Disease subjects (n = 24). After quality control we detected sSNVs (mean allele frequency = 0.134; standard deviation = 0.040) in all subjects (mean subject-level sSNV count = 229.1; standard deviation = 144.4). Comparison across H1/H1 (n = 17), H1/H2 (n = 5), and H2/H2 (n = 2) diplotypes found that H1 dosage is associated with a trend of increased autosome-wide somatic variant burden (beta = 0.361; standard error = 0.199; p = 0.088). This burden is reduced (beta = −0.619; standard error = 0.229; p = 0.016) in AD (n = 13) vs controls (n= 11). These preliminary analyses demonstrate our pipeline identifies sSNVs and performs group-level comparisons of autosome-wide somatic variant burden. We will apply this pipeline to the Accelerating Medicines Partnership-Alzheimer's Disease brain WGS dataset, which is generated from AD and control dorsolateral prefrontal cortex, frontal pole, parahippocampal gyrus, inferior frontal gyrus, temporal cortex, and superior temporal gyrus tissue (n= 1900 subjects). This large dataset will enable us to robustly evaluate relationships between H1, AD, brain region, and somatic mosaicism.

Somatic mutations in Alzheimer-associated tetraploid neurons

DNA Damage and Senescence in the Aging and Alzheimer's Disease Cortex Are Not Uniformly Distributed

Somatic genomic changes in single Alzheimer’s disease neurons

Aging and neurodegeneration are associated with increased mutations in single human neurons

Somatic cancer driver mutations are enriched and associated with inflammatory states in Alzheimer’s disease microglia

On the identification of low allele frequency mosaic mutations in the brains of Alzheimer's disease patients

Contributions of DNA Damage to Alzheimer’s Disease

Prevalence and mechanisms of somatic deletions in single human neurons during normal aging and in DNA repair disorders

P4‐487: BRAIN SOMATIC MOSAICISM IN 17Q21.31 MAPT H1‐ASSOCIATED ALZHEIMER'S DISEASE

Early oxidative stress and DNA damage in Aβ-burdened hippocampal neurons in an Alzheimer's-like transgenic rat model

Increased Nuclear DNA Oxidation in the Brain in Alzheimer's Disease

Mitochondrial DNA Damage as a Mechanism of Cell Loss in Alzheimer's Disease

Loss of Adaptive DNA Breaks in Alzheimer's Disease Brains

Absence of coding somatic single nucleotide variants within well-known candidate genes in late-onset sporadic Alzheimer's Disease based on the analysis of multi-omics data

Alzheimer’s disease induced neurons bearing mutations exhibit reduced excitability

Bulk and Single-Nucleus Transcriptomics Highlight Intra-Telencephalic and Somatostatin Neurons in Alzheimer's Disease

Adaptive and Maladaptive DNA Breaks in Neuronal Physiology and Alzheimer's Disease

Endogenous neuronal DNA double-strand breaks are not sufficient to drive brain aging and neurodegeneration

Single-nucleus RNA sequencing demonstrates an autosomal dominant Alzheimer’s disease profile and possible mechanisms of disease protection

Single-nucleus RNA sequencing demonstrates an autosomal dominant Alzheimer's disease profile and possible mechanisms of disease protection